Goleij P, Heidari M, Tabari M, Hadipour M, Rezaee A, Javan A
Funct Integr Genomics. 2025; 25(1):53.
PMID: 40048009
DOI: 10.1007/s10142-025-01563-8.
Buhler D, Hilpert M, Barbero A, Muller A, Muller S, Martin I
Bone Joint Res. 2025; 14(2):143-154.
PMID: 39996291
PMC: 11851219.
DOI: 10.1302/2046-3758.142.BJR-2023-0378.R2.
Lyu W, Wang H, Ji T, Liu L, Chen H, Fan L
Clin Transl Med. 2025; 15(2):e70217.
PMID: 39888275
PMC: 11782969.
DOI: 10.1002/ctm2.70217.
Sun W, Hewitt S, Wright H, Keller C, Barr F
J Pathol. 2025; 265(3):316-329.
PMID: 39812007
PMC: 11794984.
DOI: 10.1002/path.6386.
Zhang J, Zhao Y, Liang R, Zhou X, Wang Z, Yang C
Acta Pharm Sin B. 2025; 14(12):5219-5234.
PMID: 39807333
PMC: 11725086.
DOI: 10.1016/j.apsb.2024.08.025.
Gestational diabetes mellitus causes genome hyper-methylation of oocyte via increased EZH2.
Guo H, Tang S, Li L, Lin J, Zhang T, Chao S
Nat Commun. 2025; 16(1):127.
PMID: 39747080
PMC: 11696910.
DOI: 10.1038/s41467-024-55499-x.
NSD3 protein methylation and stabilization transforms human ES cells into variant state.
Krishnamoorthy V, Hamdani F, Shukla P, Rao R, Anaitullah S, Biligiri K
Life Sci Alliance. 2024; 8(3.
PMID: 39741006
PMC: 11707394.
DOI: 10.26508/lsa.202402871.
The therapeutic potential of RNA m(6)A in lung cancer.
Yu J, Sun W, Zhao X, Chen Y
Cell Commun Signal. 2024; 22(1):617.
PMID: 39736743
PMC: 11687105.
DOI: 10.1186/s12964-024-01980-5.
Time is encoded by methylation changes at clustered CpG sites.
Ochana B, Nudelman D, Cohen D, Peretz A, Piyanzin S, Gal O
bioRxiv. 2024; .
PMID: 39677642
PMC: 11642928.
DOI: 10.1101/2024.12.03.626674.
The role of curcumin in modulating circular RNAs and long non-coding RNAs in cancer.
Rismanchi H, Malek Mohammadi M, Mafi A, Khalilzadeh P, Farahani N, Mirzaei S
Clin Transl Oncol. 2024; .
PMID: 39623194
DOI: 10.1007/s12094-024-03782-0.
ASXL1 truncating variants in BOS and myeloid leukemia drive shared disruption of Wnt-signaling pathways but have differential isoform usage of RUNX3.
Lin I, Awamleh Z, Sinvhal M, Wan A, Bondhus L, Wei A
BMC Med Genomics. 2024; 17(1):282.
PMID: 39614348
PMC: 11606099.
DOI: 10.1186/s12920-024-02039-7.
Ezh2 Delays Activation of Differentiation Genes During Normal Cerebellar Granule Neuron Development and in Medulloblastoma.
Purzner J, Brown A, Purzner T, Ellis L, Broski S, Litzenburger U
bioRxiv. 2024; .
PMID: 39605517
PMC: 11601632.
DOI: 10.1101/2024.11.21.624171.
Plasma DNA Methylation-Based Biomarkers for MPNST Detection in Patients With Neurofibromatosis Type 1.
Tomczak K, Patel M, Bhalla A, Peterson C, Landers S, Callahan S
Mol Carcinog. 2024; 64(1):44-56.
PMID: 39600120
PMC: 11636586.
DOI: 10.1002/mc.23825.
The Role of HDAC6 in Glioblastoma Multiforme: A New Avenue to Therapeutic Interventions?.
Spallotta F, Illi B
Biomedicines. 2024; 12(11).
PMID: 39595195
PMC: 11591585.
DOI: 10.3390/biomedicines12112631.
EZH2 inhibition or genetic ablation suppresses cyst growth in autosomal dominant polycystic kidney disease.
Lv J, Lan B, Fu L, He C, Zhou W, Wang X
J Transl Med. 2024; 22(1):979.
PMID: 39472935
PMC: 11520870.
DOI: 10.1186/s12967-024-05785-5.
Epigenetic Reprogramming and Inheritance of the Cellular Differentiation Status Following Transient Expression of a Nonfunctional Dominant-Negative Retinoblastoma Mutant in Murine Mesenchymal Stem Cells.
Baryshev M, Maksimova I, Sasoveca I
Int J Mol Sci. 2024; 25(19).
PMID: 39409007
PMC: 11476944.
DOI: 10.3390/ijms251910678.
SCAR-6 elncRNA locus epigenetically regulates PROZ and modulates coagulation and vascular function.
Ranjan G, Sehgal P, Scaria V, Sivasubbu S
EMBO Rep. 2024; 25(11):4950-4978.
PMID: 39358551
PMC: 11549340.
DOI: 10.1038/s44319-024-00272-w.
Epigenome Reprogramming Through H3K27 and H3K4 Trimethylation as a Resistance Mechanism to DNA Methylation Inhibition in BRAFV600E-Mutated Colorectal Cancer.
Lee H, Saw A, Morris V, Napolitano S, Bristow C, Srinivasan S
Clin Cancer Res. 2024; 30(22):5166-5179.
PMID: 39269307
PMC: 11829253.
DOI: 10.1158/1078-0432.CCR-24-1166.
Cancer-associated DNA hypermethylation of Polycomb targets requires DNMT3A dual recognition of histone H2AK119 ubiquitination and the nucleosome acidic patch.
Gretarsson K, Abini-Agbomson S, Gloor S, Weinberg D, McCuiston J, Kumary V
Sci Adv. 2024; 10(35):eadp0975.
PMID: 39196936
PMC: 11352909.
DOI: 10.1126/sciadv.adp0975.
Dual-target EZH2 inhibitor: latest advances in medicinal chemistry.
Wei L, Mei D, Hu S, Du S
Future Med Chem. 2024; 16(15):1561-1582.
PMID: 39082677
PMC: 11370917.
DOI: 10.1080/17568919.2024.2380243.